Assessing Treatment Response of Glioblastoma to an HDAC Inhibitor Using Whole-Brain Spectroscopic MRI. [electronic resource]
Producer: 20200203Description: 53-60 p. digitalISSN:- 2379-139X
- Adult
- Aged
- Animals
- Antidepressive Agents -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Behavior, Animal -- drug effects
- Brain Neoplasms -- diagnostic imaging
- Depression -- drug therapy
- Dose-Response Relationship, Drug
- Female
- Glioblastoma -- diagnostic imaging
- Histone Deacetylase Inhibitors -- administration & dosage
- Humans
- Hydroxamic Acids -- administration & dosage
- Kaplan-Meier Estimate
- Magnetic Resonance Imaging -- methods
- Male
- Middle Aged
- Neoplasm Transplantation
- Pilot Projects
- Rats, Inbred F344
- Sulfonamides -- administration & dosage
- Treatment Outcome
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Controlled Clinical Trial; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.